Oral Leukoplakia
What's New
Last Posted: Sep 13, 2024
- Association between 35 blood and urine biomarkers and oral leukoplakia: a two-sample Mendelian randomization study.
Yu-Long Ouyang, et al. Frontiers in oncology 2024 0 1437493 - Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
Camile S Farah, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2024 0 - Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias.
Anne Anuhya, et al. Cytogenetic and genome research 2023 0 - The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species.
Amer Abdrazak, et al. Frontiers in microbiology 2017 0 2391 - Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO and Diode Laser.
Galletta Vivian, et al. The journal of contemporary dental practice 2017 0 (9) 775-780 - Detection of HPV in oral leukoplakia by brushing and biopsy: prospective study in an Italian cohort.
Della Vella Fedora, et al. Clinical oral investigations 2019 0 (5) 1845-1851 - Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation.
Farah Camile S, et al. Oral oncology 2019 0 42-50 - Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
Li Jin, et al. Oral diseases 2020 0 (7) 1402-1413 - Chronic disease comorbidity in patients with oral leukoplakia: A matched case-control study.
Giudice Lance W, et al. Oral diseases 2020 0 (5) 894-902 - Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils Leon J, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 0 (3) 602-613 - Association Between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Risk of Oral Leukoplakia: A Meta-analysis.
Wang Jiayi, et al. Genetic testing and molecular biomarkers 2021 0 (12) 781-787 - Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia.
Xinyi Zhang et al. Cancer medicine 2023 - Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
Savage Sharon A, et al. Journal of medical genetics 2011 0 (4) 285-8 - Deep Learning Predicts the Malignant-Transformation-Free Survival of Oral Potentially Malignant Disorders.
Adeoye John et al. Cancers 2021 13(23) - Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
Hernández-Arenas Yuritza Y, et al. Journal of oral biosciences 2021 2 - Study of Caspase 8 mutation in oral cancer and adjacent precancer tissues and implication in progression.
Singh Richa, et al. PloS one 2020 0 (6) e0233058 - Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Thomas Gigi et al. Asian Pacific journal of cancer prevention : APJCP 2020 Feb 21(2) 309-316 - Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients.
Zarate Ana Maria, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 5 (5) 1010428317699113 - Oral keratosis of unknown significance shares genomic overlap with oral dysplasia.
Villa Alessandro, et al. Oral diseases 2019 7 - Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
Sun Zhen, et al. BMC oral health 2018 8 (1) 143 - Salivary biomarkers and proteomics: future diagnostic and clinical utilities.
Castagnola M et al. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2017 Apr 37(2) 94-101 - Evaluation of Genetic Polymorphisms in Glutathione S-Transferase Theta1, Glutathione S-Transferase Mu1, and Glutathione S-Transferase Mu3 in Oral Leukoplakia and Oral Squamous Cell Carcinoma with Deleterious Habits using Polymerase Chain Reaction.
Rao Ayyagari Kameswara, et al. International journal of applied & basic medical research 0 0 (3) 181-185 - The variant of pri-mir-26a-1 polymorphism is associated with decreased risk of betel quid-related oral premalignant lesions and oral squamous cell carcinoma.
Yang Cheng-Mei, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2017 6 - GSTM1 null polymorphism prevalence in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.
Tanwar Renu, et al. Indian journal of dental research : official publication of Indian Society for Dental Research 0 0 (4) 353-358 - Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer.
Chen Hung-Chih, et al. Archives of oral biology 2016 8 21-32 - Associations Among Glutathione S-Transferase T1, M1, and P1 Polymorphisms and the Risk of Oral Leukoplakia.
He Pengfei, et al. Genetic testing and molecular biomarkers 2016 5 - Association of DNA sequence variation in mitochondrial DNA polymerase with mitochondrial DNA synthesis and risk of oral cancer.
Datta Sayantan, et al. Gene 2015 9 - Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer.
Datta Sayantan, et al. Mitochondrion 2015 9 - Role of CYP2E1 genetic polymorphism in the development of oral leukoplakia among tobacco users in North Indian population.
Gupta S, et al. Indian journal of cancer 0 0 (2) 154-8 - Prevalence of glutathione S-transferase M1 null polymorphism in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.
Tanwar Renu, et al. Contemporary clinical dentistry 2015 3 (Suppl 1) S59-64
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: